Inspira Technologies Oxy BHN Ltd - Asset Resilience Ratio
Inspira Technologies Oxy BHN Ltd (IINN) has an Asset Resilience Ratio of 8.28% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Inspira Technologies Oxy BHN Ltd total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2024)
This chart shows how Inspira Technologies Oxy BHN Ltd's Asset Resilience Ratio has changed over time. See IINN total equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Inspira Technologies Oxy BHN Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Inspira Technologies Oxy BHN Ltd market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $668.00K | 8.28% |
| Total Liquid Assets | $668.00K | 8.28% |
Asset Resilience Insights
- Limited Liquidity: Inspira Technologies Oxy BHN Ltd maintains only 8.28% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Inspira Technologies Oxy BHN Ltd Industry Peers by Asset Resilience Ratio
Compare Inspira Technologies Oxy BHN Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 3.37% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS |
Medical Devices | 54.67% |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO |
Medical Devices | 30.97% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
|
Acarix A/S
ST:ACARIX |
Medical Devices | 37.81% |
Annual Asset Resilience Ratio for Inspira Technologies Oxy BHN Ltd (2022–2024)
The table below shows the annual Asset Resilience Ratio data for Inspira Technologies Oxy BHN Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 8.28% | $668.00K | $8.07 Million | -16.64pp |
| 2023-12-31 | 24.92% | $2.32 Million | $9.31 Million | -19.55pp |
| 2022-12-31 | 44.47% | $7.12 Million | $16.01 Million | -- |
About Inspira Technologies Oxy BHN Ltd
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. The company was formerly known as In… Read more